Victory Capital Management’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $138K | Sell |
17,119
-343,710
| -95% | -$2.78M | ﹤0.01% | 2299 |
|
|
2025
Q1 | $3.02M | Buy |
360,829
+149,699
| +71% | +$1.25M | ﹤0.01% | 1430 |
|
|
2024
Q4 | $1.67M | Buy |
211,130
+111,915
| +113% | +$886K | ﹤0.01% | 1572 |
|
|
2024
Q3 | $825K | Buy |
99,215
+36,700
| +59% | +$305K | ﹤0.01% | 1853 |
|
|
2024
Q2 | $397K | Sell |
62,515
-90,568
| -59% | -$575K | ﹤0.01% | 2032 |
|
|
2024
Q1 | $928K | Sell |
153,083
-142,615
| -48% | -$864K | ﹤0.01% | 1779 |
|
|
2023
Q4 | $1.79M | Sell |
295,698
-13,534
| -4% | -$82.2K | ﹤0.01% | 1455 |
|
|
2023
Q3 | $1.3M | Buy |
309,232
+406
| +0.1% | +$1.71K | ﹤0.01% | 1529 |
|
|
2023
Q2 | $957K | Sell |
308,826
-255
| -0.1% | -$791 | ﹤0.01% | 1703 |
|
|
2023
Q1 | $430K | Buy |
309,081
+69,360
| +29% | +$96.4K | ﹤0.01% | 2041 |
|
|
2022
Q4 | $477K | Buy |
239,721
+44,457
| +23% | +$88.5K | ﹤0.01% | 2025 |
|
|
2022
Q3 | $394K | Sell |
195,264
-629,924
| -76% | -$1.27M | ﹤0.01% | 2151 |
|
|
2022
Q2 | $2.62M | Sell |
825,188
-385,163
| -32% | -$1.22M | ﹤0.01% | 1392 |
|
|
2022
Q1 | $4.98M | Buy |
1,210,351
+30,700
| +3% | +$126K | 0.01% | 1298 |
|
|
2021
Q4 | $5.65M | Buy |
1,179,651
+170,018
| +17% | +$814K | 0.01% | 1298 |
|
|
2021
Q3 | $5.39M | Sell |
1,009,633
-911,857
| -47% | -$4.87M | 0.01% | 1312 |
|
|
2021
Q2 | $9.84M | Buy |
1,921,490
+133,828
| +7% | +$685K | 0.01% | 1136 |
|
|
2021
Q1 | $12M | Buy |
1,787,662
+1,616,423
| +944% | +$10.9M | 0.01% | 1086 |
|
|
2020
Q4 | $783K | Buy |
171,239
+73,602
| +75% | +$337K | ﹤0.01% | 1888 |
|
|
2020
Q3 | $379K | Buy |
97,637
+50,815
| +109% | +$197K | ﹤0.01% | 2068 |
|
|
2020
Q2 | $223K | Sell |
46,822
-49,588
| -51% | -$236K | ﹤0.01% | 2270 |
|
|
2020
Q1 | $336K | Buy |
96,410
+41,302
| +75% | +$144K | ﹤0.01% | 2212 |
|
|
2019
Q4 | $266K | Buy |
55,108
+5,066
| +10% | +$24.5K | ﹤0.01% | 2233 |
|
|
2019
Q3 | $145K | Buy |
+50,042
| New | +$145K | ﹤0.01% | 2316 |
|